JP6213560B2 - 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法 - Google Patents

薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法 Download PDF

Info

Publication number
JP6213560B2
JP6213560B2 JP2015509510A JP2015509510A JP6213560B2 JP 6213560 B2 JP6213560 B2 JP 6213560B2 JP 2015509510 A JP2015509510 A JP 2015509510A JP 2015509510 A JP2015509510 A JP 2015509510A JP 6213560 B2 JP6213560 B2 JP 6213560B2
Authority
JP
Japan
Prior art keywords
implant
eye
latanoprost
iop
lacrimal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015509510A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015520628A5 (enExample
JP2015520628A (ja
Inventor
ディーパンク ウッケーデ、
ディーパンク ウッケーデ、
スザンヌ カッデン、
スザンヌ カッデン、
ハオ、ヨン
Original Assignee
マティ セラピューティクス，インク．
マティ セラピューティクス，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マティ セラピューティクス，インク．, マティ セラピューティクス，インク． filed Critical マティ セラピューティクス，インク．
Publication of JP2015520628A publication Critical patent/JP2015520628A/ja
Publication of JP2015520628A5 publication Critical patent/JP2015520628A5/ja
Application granted granted Critical
Publication of JP6213560B2 publication Critical patent/JP6213560B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
JP2015509510A 2012-05-03 2013-02-27 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法 Active JP6213560B2 (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201261642287P 2012-05-03 2012-05-03
US61/642,287 2012-05-03
US201261644401P 2012-05-08 2012-05-08
US201261644397P 2012-05-08 2012-05-08
US61/644,401 2012-05-08
US61/644,397 2012-05-08
US201261659921P 2012-06-14 2012-06-14
US61/659,921 2012-06-14
US201261680641P 2012-08-07 2012-08-07
US61/680,641 2012-08-07
US201261717615P 2012-10-23 2012-10-23
US61/717,615 2012-10-23
PCT/IB2013/000694 WO2013164671A1 (en) 2012-05-03 2013-02-27 Drug delivery system and methods of treating open angle glaucoma and ocular hypertension

Publications (3)

Publication Number Publication Date
JP2015520628A JP2015520628A (ja) 2015-07-23
JP2015520628A5 JP2015520628A5 (enExample) 2016-04-14
JP6213560B2 true JP6213560B2 (ja) 2017-10-18

Family

ID=49514247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015509510A Active JP6213560B2 (ja) 2012-05-03 2013-02-27 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法

Country Status (7)

Country Link
EP (1) EP2844224B1 (enExample)
JP (1) JP6213560B2 (enExample)
CN (1) CN105473130A (enExample)
CA (1) CA2872338C (enExample)
HK (1) HK1222810A1 (enExample)
IN (1) IN2014DN09713A (enExample)
WO (1) WO2013164671A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG187770A1 (en) 2010-08-12 2013-03-28 Univ Nanyang Tech A liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
GB201714392D0 (en) * 2017-09-07 2017-10-25 Marsteller Laurence Methods and devices for treating glaucoma

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321108A (en) 1965-11-26 1967-05-23 William E Bowe Printing ink dispenser
US3681608A (en) 1971-03-17 1972-08-01 Us Navy Laser beam receiver having a high signal to noise ratio
US4281654A (en) 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US4936008A (en) 1988-05-09 1990-06-26 Teledyne Mec Laser striping method for assembling TWT
US4934708A (en) 1988-05-20 1990-06-19 Kolkind Gerald L Family quiz board game
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5259508A (en) 1992-08-27 1993-11-09 Beckerman Stephen M Protective shipping package
ES2105333T3 (es) 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
US6622308B1 (en) 1999-03-23 2003-09-16 Scientific-Atlanta, Inc. Automatic digital television (DTV) bypass for a CATV converter using a CATV tuner
US6534693B2 (en) 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7300364B2 (en) 2004-02-06 2007-11-27 Acushnet Company Multi-layer golf ball having velocity gradient from faster center to slower cover
AU2004215898A1 (en) 2003-02-26 2004-09-10 Medivas, Llc Bioactive stents and methods for use thereof
JP4104137B2 (ja) * 2003-05-30 2008-06-18 有限会社エム・エル・シー 涙点プラグ
US7662864B2 (en) 2003-06-04 2010-02-16 Rutgers, The State University Of New Jersey Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent
US20050129731A1 (en) 2003-11-03 2005-06-16 Roland Horres Biocompatible, biostable coating of medical surfaces
KR100850133B1 (ko) 2004-01-05 2008-08-04 니콕스 에스. 에이. 프로스타글란딘 나이트로옥시 유도체
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
AU2005269988B2 (en) 2004-07-02 2012-02-02 Mati Therapeutics Inc. Treatment medium delivery device and methods for delivery
CA2648066C (en) 2006-03-31 2012-07-03 Forsight Labs, Llc Drug delivery methods, structures, and compositions for nasolacrimal system
WO2008083118A1 (en) * 2006-12-26 2008-07-10 Qlt Plug Delivery, Inc. Drug delivery implants for inhibition of optical defects
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
CA2698508C (en) 2007-09-07 2017-06-06 Alan R. Rapacki Lacrimal implants and related methods
RU2010112417A (ru) 2007-09-07 2011-10-10 Клт Плаг Диливери, Инк. (Us) Обнаружение лакримальных имплантатов
KR20100058620A (ko) 2007-09-07 2010-06-03 큐엘티 플러그 딜리버리, 인코포레이티드 눈물 임플랜트용 삽입 및 적출 기구
JP5555162B2 (ja) 2007-09-07 2014-07-23 キュー エル ティー インク． 治療薬剤の持続放出のための薬物コア
WO2009137085A2 (en) * 2008-05-09 2009-11-12 Qlt Plug Delivery, Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
EP2389221B1 (en) 2009-01-23 2023-08-16 Mati Therapeutics Inc. Sustained released delivery of one or more agents
SG174133A1 (en) * 2009-02-23 2011-10-28 Quadra Logic Tech Inc Lacrimal implants and related methods
CA2781629A1 (en) 2009-11-27 2011-06-03 Sascha K. Zarins Lacrimal implants including split and insertable drug core

Also Published As

Publication number Publication date
WO2013164671A1 (en) 2013-11-07
IN2014DN09713A (enExample) 2015-07-31
CA2872338C (en) 2021-09-14
JP2015520628A (ja) 2015-07-23
EP2844224A4 (en) 2016-02-24
CN105473130A (zh) 2016-04-06
EP2844224B1 (en) 2018-04-11
CA2872338A1 (en) 2013-11-07
HK1222810A1 (zh) 2017-07-14
EP2844224A1 (en) 2015-03-11

Similar Documents

Publication Publication Date Title
JP6100782B2 (ja) 緑内障および高眼圧症を治療するための活性剤の徐放送達
EP2389221B1 (en) Sustained released delivery of one or more agents
TWI454285B (zh) 治療青光眼及高眼壓之活性劑之持續釋放輸送
US9974685B2 (en) Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
CN102105118A (zh) 青光眼的联合治疗
JP6213560B2 (ja) 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法
HK1162151B (en) Sustained released delivery of one or more agents
HK1158951A (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160225

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160225

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20161214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161220

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170317

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170620

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170704

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170803

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20170904

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170904

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170906

R150 Certificate of patent or registration of utility model

Ref document number: 6213560

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250